Moreover, this HyBNAR model can serve as a perfect platform to investigate the relationship between IFNAR receptor levels, IFN-I binding affinity and their potency to the added effects of injected Hu-IFN-Is in cancer and in immune-related diseases. This evidence concerns the gene IFNA1 and cancer.